2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Congenital Ichthyosis: new trials by email Literature Review of Congenital Ichthyosis trials Research Report on Congenital Ichthyosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis Isotretinoin, Vehicle - Congenital Ichthyosis | Phase 2 | Completed | LEO Pharma | 34 | 2019-12-03 | 2026-05-22 |
| A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis PAT-001, 0.1%, PAT-001, 0.2%, Vehicle for PAT-001 0.1% - Congenital Ichthyosis | Phase 2 | Completed | Patagonia Pharmaceuticals, LLC | 19 | 2017-03-08 | 2021-09-29 |
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Ichthyosis (2) · Keratosis (2) · Skin Abnormalities (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2)
Isotretinoin (1)
LEO Pharma (1) · Patagonia Pharmaceuticals, LLC (1)
United States (2) · Australia (1)
Zachary Rome, BS (1)